AR003001A1 - Composicion farmaceutica estimuladora de la osteogenesis. - Google Patents
Composicion farmaceutica estimuladora de la osteogenesis.Info
- Publication number
- AR003001A1 AR003001A1 ARP960102893A AR10289396A AR003001A1 AR 003001 A1 AR003001 A1 AR 003001A1 AR P960102893 A ARP960102893 A AR P960102893A AR 10289396 A AR10289396 A AR 10289396A AR 003001 A1 AR003001 A1 AR 003001A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- stimulating osteogenesis
- composition stimulating
- osteogenesis
- prophylactic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13803695 | 1995-06-05 | ||
| JP1168696 | 1996-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR003001A1 true AR003001A1 (es) | 1998-05-27 |
Family
ID=26347166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960102893A AR003001A1 (es) | 1995-06-05 | 1996-06-04 | Composicion farmaceutica estimuladora de la osteogenesis. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0831808A1 (zh) |
| KR (1) | KR19990022514A (zh) |
| AR (1) | AR003001A1 (zh) |
| AU (1) | AU717260B2 (zh) |
| CA (1) | CA2221784A1 (zh) |
| HU (1) | HUP9802573A3 (zh) |
| NO (1) | NO975636L (zh) |
| NZ (1) | NZ308658A (zh) |
| RU (1) | RU2188011C2 (zh) |
| TW (1) | TW420608B (zh) |
| WO (1) | WO1996039134A1 (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0949927B1 (en) | 1996-08-26 | 2002-10-16 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol |
| WO1999065474A2 (en) * | 1998-06-15 | 1999-12-23 | Takeda Chemical Industries, Ltd. | Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds |
| US6355672B1 (en) | 1998-08-07 | 2002-03-12 | Takeda Chemical Industries, Ltd. | Benzothiepin derivatives, process for the preparation of the same and uses thereof |
| WO2000009100A2 (en) * | 1998-08-12 | 2000-02-24 | Takeda Chemical Industries, Ltd. | Benzothiepine compounds as enhancer of cell differentiation induction factor |
| WO2001089521A1 (fr) * | 2000-05-23 | 2001-11-29 | Takeda Chemical Industries, Ltd. | Compositions medicinales contenant des derives du tiophene |
| US6926903B2 (en) | 2001-12-04 | 2005-08-09 | Inion Ltd. | Resorbable polymer composition, implant and method of making implant |
| JP4723864B2 (ja) * | 2002-12-19 | 2011-07-13 | 日本曹達株式会社 | Ｏｉｌ／Ｗａｔｅｒ液中乾燥法による農薬マイクロカプセル製剤及びその製造方法 |
| US9814657B2 (en) | 2009-04-27 | 2017-11-14 | Premier Dental Products Company | Buffered microencapsulated compositions and methods |
| US8889161B2 (en) | 2009-04-27 | 2014-11-18 | Premier Dental Products Company | Microencapsulated compositions and methods for tissue mineralization |
| TWI458503B (zh) * | 2013-04-22 | 2014-11-01 | Medical & Pharm Ind Tech & Dev | 維生素ｋ微球、其製造方法、用途、及藥劑 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2157887T3 (es) * | 1990-05-30 | 2001-09-01 | Takeda Chemical Industries Ltd | Compuestos heterociclicos que contienen azufre. |
| CN1151744A (zh) * | 1994-07-04 | 1997-06-11 | 武田药品工业株式会社 | 膦酸化合物及其制备和应用 |
| TW403757B (en) * | 1994-12-28 | 2000-09-01 | Takeda Chemical Industries Ltd | Optically active benzothiepin derivative, its preparation and use |
-
1996
- 1996-06-04 KR KR1019970708995A patent/KR19990022514A/ko not_active Application Discontinuation
- 1996-06-04 AU AU58457/96A patent/AU717260B2/en not_active Ceased
- 1996-06-04 EP EP96920042A patent/EP0831808A1/en not_active Withdrawn
- 1996-06-04 NZ NZ308658A patent/NZ308658A/en unknown
- 1996-06-04 AR ARP960102893A patent/AR003001A1/es unknown
- 1996-06-04 CA CA002221784A patent/CA2221784A1/en not_active Abandoned
- 1996-06-04 RU RU98100111/14A patent/RU2188011C2/ru not_active IP Right Cessation
- 1996-06-04 WO PCT/JP1996/001506 patent/WO1996039134A1/en not_active Application Discontinuation
- 1996-06-04 HU HU9802573A patent/HUP9802573A3/hu unknown
- 1996-06-05 TW TW085106698A patent/TW420608B/zh not_active IP Right Cessation
-
1997
- 1997-12-04 NO NO975636A patent/NO975636L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0831808A1 (en) | 1998-04-01 |
| HUP9802573A3 (en) | 2000-04-28 |
| NO975636L (no) | 1998-01-28 |
| HUP9802573A2 (hu) | 1999-09-28 |
| TW420608B (en) | 2001-02-01 |
| KR19990022514A (ko) | 1999-03-25 |
| CA2221784A1 (en) | 1996-12-12 |
| AU717260B2 (en) | 2000-03-23 |
| NO975636D0 (no) | 1997-12-04 |
| RU2188011C2 (ru) | 2002-08-27 |
| AU5845796A (en) | 1996-12-24 |
| NZ308658A (en) | 1999-10-28 |
| WO1996039134A1 (en) | 1996-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002041837A3 (en) | Treatment of mucositis | |
| AR020055A1 (es) | Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma. | |
| EE04221B1 (et) | Östrogeeni kasutamine ravimi valmistamiseks füüsiliste seisundite raviks menopausijärgsetel isikutel | |
| AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
| HRP20020593B1 (en) | Brain, spinal and nerve injury treatment | |
| BR9600353A (pt) | Processo para melhoria da segurança de dispositivos cirúrgicos implantáveis fixados em tecido ósseo e dispositivo cirúrgico | |
| GT199700009AA (es) | Terapia combinada para la osteoporosis | |
| ES2140469T3 (es) | Composiciones y metodos terapeuticos y de diagnostico por obtencion de imagenes. | |
| ES2060310T3 (es) | Utilizacion de la n-miristoil-(s)-fenilalanina para la obtencion de medicamentos destinados al tratamiento de enfermedades que hacen intervenir la miristoilacion. | |
| BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
| WO2001078830A3 (en) | Photostimulaton treatment apparatus and methods for use | |
| AU2001247968A1 (en) | Use of asiatic acid or asiaticoside for treatment of cancer | |
| ES2181017T3 (es) | Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol. | |
| AR003001A1 (es) | Composicion farmaceutica estimuladora de la osteogenesis. | |
| AR034493A1 (es) | Combinacion de principios activos para el tratamiento medico de toxicomanias. | |
| ES2180729T3 (es) | Tratamiento terapeutico combinado de las patologias hiperproliferantes. | |
| ES2041243T3 (es) | Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus. | |
| BR0111024A (pt) | Composições e métodos para a terapia e diagnóstico de câncer de mama | |
| IT1289154B1 (it) | Derivati di isoflavone loro preparazione e loro impiego terapeutico | |
| ES2190581T3 (es) | 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico. | |
| NZ332412A (en) | use of interleuklin-10 for treating or preventing ischemia-reperfusion injury | |
| TR199901385T2 (xx) | Piperidin t�revleri. | |
| DE9404106U1 (de) | Vorrichtung zur gezielten Heilbehandlung von erkrankten Zellen, Organen, Geweben o.dgl. | |
| MD1270F1 (en) | Method for treatment of the hand navicular bone pseudarthrosis | |
| UA32314A (uk) | Спосіб лікування некротичного панкреатиту |